PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Provectus Biopharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Provectus Biopharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 420M shares, a 0.18% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 420M +758K +0.18% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 420M +25K +0.01% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 420M +25K +0.01% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 419M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 420M +25K +0.01% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 419M +50K +0.01% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 419M +50K +0.01% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 419M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 419M +50K +0.01% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 419M +15.7M +3.88% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 419M +15.9M +3.94% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 419M +20.6M +5.18% Dec 31, 2021 10-K 2023-03-30
Q3 2021 419M +22.6M +5.69% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 404M +13.1M +3.35% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 404M +12.9M +3.29% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 399M +8.92M +2.29% Dec 31, 2020 10-K 2022-03-29
Q3 2020 397M +8.28M +2.13% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 391M +5.81M +1.51% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 391M +5.97M +1.55% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 390M +5.27M +1.37% Dec 31, 2019 10-K 2021-03-02
Q3 2019 389M +5.08M +1.32% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 385M +1.8M +0.47% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 385M +5.83M +1.54% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 385M +13.7M +3.68% Dec 31, 2018 10-K 2020-03-05
Q3 2018 384M +12.8M +3.44% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 383M +12.8M +3.44% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 379M +8.53M +2.3% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 371M +6.19M +1.7% Dec 31, 2017 10-K 2019-03-07
Q3 2017 371M +127M +52% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 370M +158M +74% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 370M +158M +74% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 365M +160M +78% Dec 31, 2016 10-K 2018-03-23
Q3 2016 244M +39.3M +19.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 213M +8.27M +4.04% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 213M +26.9M +14.4% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 205M +20.2M +10.9% Dec 31, 2015 10-K 2017-03-31
Q3 2015 205M +24.3M +13.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 205M +27.9M +15.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 186M +12.8M +7.42% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 185M +25M +15.7% Dec 31, 2014 10-K 2016-03-30
Q3 2014 180M +40.3M +28.8% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 177M +48M +37.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 173M +48.6M +39% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 160M +41.3M +34.9% Dec 31, 2013 10-K 2015-03-12
Q3 2013 140M +29.4M +26.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 129M +18M +16.3% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 125M +13.6M +12.3% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 118M +7.83M +7.08% Dec 31, 2012 10-K 2014-03-13
Q3 2012 111M +956K +0.87% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 111M +1.94M +1.78% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 111M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 111M +19.3M +21.1% Dec 31, 2011 10-K 2013-03-14
Q3 2011 110M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 109M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 91.3M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.